Cohorte Des Maladies Auto-Immunes du Foie
Cohorte Des Maladies Auto-Immunes du Foie
The MAI-FOIE cohort will be a French multicenter cohort with the development of a biobank including patients with autoimmune, metabolic and medicated liver diseases
The MAI-FOIE cohort will be a prospective cohort of patients with autoimmune liver diseases followed up in 13 French centers. The multicentric nature of the cohort is a major asset, enabling the enrolment of a broad spectrum of patients, from those naïve to any immunomodulatory treatment to those refractory to therapies. The goal is to identify different treatment response profiles, markers of remission and markers of relapse risk after discontinuation of immunosuppressants in order to improve patient care.
AIH (Auto-Immune Hepatitis) patients :
Inclusion Criteria :
age≥10 years old
weight≥25kg
AIH (with or without the presence of an overlap) whose diagnosis is validated by at least 2 of the following criteria :
signing of a written consent form for participation in the study and for the storage of biological samples research
Control patients :
age≥18 years old
weight≥37kg
Patient with one of the following 3 conditions :
Exclusion Criteria :
Positive HIV serology HBV infection Positive HCV serology and PCR Patients under guardianship or curatorship
Jerome.gournay@chu-nantes.fr+33 2.40.08.31.52
jean-baptiste.nousbaum@chu-brest.fr
audrey.payance@aphp.fr
matthieu.schnee@chd-vendee.fr
alexandre.louvet@chu-lille.fr
Jerome.dumortier@chu-lyon.fr
Jerome.gournay@chu-nantes.fr+33 2.40.08.31.52
sara.lemoinne@aphp.fr
christine.silvain@chu-poitiers.fr
edouard.bardou-jacquet@chu-rennes.fr
Bureau.c@chu-toulouse.fr
l.elkrief@chu-tours.fr
eleonora.demartin@aphp.fr